These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 27587606

  • 1. Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.
    Servais A, Devillard N, Frémeaux-Bacchi V, Hummel A, Salomon L, Contin-Bordes C, Gomer H, Legendre C, Delmas Y.
    Nephrol Dial Transplant; 2016 Dec; 31(12):2122-2130. PubMed ID: 27587606
    [Abstract] [Full Text] [Related]

  • 2. Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab.
    Chua J, Paizis K, He SZ, Mount P.
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():18-22. PubMed ID: 28176472
    [Abstract] [Full Text] [Related]

  • 3. Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis.
    Kozlovskaya NL, Korotchaeva YV, Bobrova LA.
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2853-2859. PubMed ID: 29606012
    [Abstract] [Full Text] [Related]

  • 4. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis.
    Socié G, Caby-Tosi MP, Marantz JL, Cole A, Bedrosian CL, Gasteyger C, Mujeebuddin A, Hillmen P, Vande Walle J, Haller H.
    Br J Haematol; 2019 Apr; 185(2):297-310. PubMed ID: 30768680
    [Abstract] [Full Text] [Related]

  • 5. Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):466-474. PubMed ID: 28339660
    [Abstract] [Full Text] [Related]

  • 6. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct 01; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 7. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report.
    Alabdulqader M, Alfakeeh K.
    BMC Nephrol; 2021 Apr 20; 22(1):140. PubMed ID: 33879077
    [Abstract] [Full Text] [Related]

  • 8. Eculizumab in pregnancy: a narrative overview.
    Sarno L, Tufano A, Maruotti GM, Martinelli P, Balletta MM, Russo D.
    J Nephrol; 2019 Feb 20; 32(1):17-25. PubMed ID: 30159857
    [Abstract] [Full Text] [Related]

  • 9. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan 20; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 10. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R, San A, Kurtkoti J, Parnham A.
    Nephrology (Carlton); 2017 Feb 20; 22 Suppl 1():32-35. PubMed ID: 28176475
    [Abstract] [Full Text] [Related]

  • 11. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients.
    Terano C, Ishikura K, Hamada R, Yoshida Y, Kubota W, Okuda Y, Shinozuka S, Harada R, Iyoda S, Fujimura Y, Hamasaki Y, Hataya H, Honda M.
    Nephrology (Carlton); 2018 Jun 20; 23(6):539-545. PubMed ID: 28387984
    [Abstract] [Full Text] [Related]

  • 12. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan 20; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 13. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A, Nayer A, Haas CS.
    J Nephrol; 2017 Jun 20; 30(3):347-362. PubMed ID: 27848226
    [Abstract] [Full Text] [Related]

  • 14. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M, Tanabe K.
    Nephrology (Carlton); 2016 Jul 20; 21 Suppl 1():9-13. PubMed ID: 26988663
    [Abstract] [Full Text] [Related]

  • 15. Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy.
    Neave L, Gale DP, Cheesman S, Shah R, Scully M.
    Br J Haematol; 2019 Jul 20; 186(1):113-124. PubMed ID: 30916388
    [Abstract] [Full Text] [Related]

  • 16. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
    Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G.
    Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717
    [Abstract] [Full Text] [Related]

  • 17. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene.
    Alobaidi S, AlDabbagh A, Alamoudi A, Almowarey M, Akl A.
    CEN Case Rep; 2019 May 04; 8(2):139-143. PubMed ID: 30715674
    [Abstract] [Full Text] [Related]

  • 18. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab.
    Puri P, Hanxhiu A, O'Hara DV, Hsu D, Vucak-Dzumhur M.
    BMC Nephrol; 2020 Nov 17; 21(1):488. PubMed ID: 33203373
    [Abstract] [Full Text] [Related]

  • 19. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr 17; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 20. Interventions for atypical haemolytic uraemic syndrome.
    Pugh D, O'Sullivan ED, Duthie FA, Masson P, Kavanagh D.
    Cochrane Database Syst Rev; 2021 Mar 23; 3(3):CD012862. PubMed ID: 33783815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.